Insights

Innovative Biotechnology Platform Noveome Biotherapeutics, Inc. has an innovative platform technology that sets it apart in the biotechnology research industry. With a complex mixture of biomolecules, the company's product has the potential to treat a wide range of conditions and injuries, offering a unique selling proposition to potential clients and partners.

Significant Government Funding Noveome Biotherapeutics, Inc. has secured substantial funding from prestigious entities like the U.S. Department of Defense and the Commonwealth of Pennsylvania, amounting to a total of $170M. Highlighting this financial backing can instill confidence in potential investors and collaborators, showcasing the company's stability and growth potential.

Highly Experienced Board of Directors The company boasts a highly experienced Board of Directors, including individuals like Eric Keller and Houman D. Hemmati, who bring a wealth of knowledge and expertise to the organization. Leveraging the credibility and reputation of the board members can open doors to partnerships and collaborations within the industry.

Strategic Geographic Location Situated in Pittsburgh, a hub for biotechnological advancements, Noveome Biotherapeutics, Inc. benefits from a prime location that facilitates collaboration with major research centers and industry leaders. Emphasizing the strategic geographic positioning can attract potential clients seeking partnerships in a thriving biotech ecosystem.

Strong Market Positioning With a focus on regenerative repair of damaged tissues, Noveome Biotherapeutics, Inc. positions itself as a pioneer in developing next-generation biologics. This strong market positioning can be leveraged to showcase the company's competitive edge and relevance, making it an attractive partner for organizations seeking cutting-edge therapeutic solutions.

Similar companies to Noveome Biotherapeutics, Inc.

Noveome Biotherapeutics, Inc. Tech Stack

Noveome Biotherapeutics, Inc. uses 8 technology products and services including jsDelivr, Google Hosted Libraries, Twitter Emoji (Twemoji), and more. Explore Noveome Biotherapeutics, Inc.'s tech stack below.

  • jsDelivr
    Content Delivery Network
  • Google Hosted Libraries
    Content Delivery Network
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Open Graph
    Miscellaneous
  • RSS
    Miscellaneous
  • Android
    Programming Languages
  • Yoast SEO
    Search Engines
  • Contact Form 7
    Web Platform Extensions

Media & News

Noveome Biotherapeutics, Inc.'s Email Address Formats

Noveome Biotherapeutics, Inc. uses at least 1 format(s):
Noveome Biotherapeutics, Inc. Email FormatsExamplePercentage
FLast@noveome.comJDoe@noveome.com
48%
FirstLast@noveome.comJohnDoe@noveome.com
2%
FLast@noveome.comJDoe@noveome.com
48%
FirstLast@noveome.comJohnDoe@noveome.com
2%

Frequently Asked Questions

Where is Noveome Biotherapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Noveome Biotherapeutics, Inc.'s main headquarters is located at 100 Technology Drive Suite 200 Pittsburgh, PA 15219 US. The company has employees across 1 continents, including North America.

What is Noveome Biotherapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Noveome Biotherapeutics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Noveome Biotherapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Noveome Biotherapeutics, Inc.'s official website is noveome.com and has social profiles on LinkedIn.

How much revenue does Noveome Biotherapeutics, Inc. generate?

Minus sign iconPlus sign icon
As of November 2024, Noveome Biotherapeutics, Inc.'s annual revenue reached $3.8M.

What is Noveome Biotherapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Noveome Biotherapeutics, Inc.'s SIC code is 6719 - Offices of Holding Companies, Not Elsewhere Classified NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Noveome Biotherapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of November 2024, Noveome Biotherapeutics, Inc. has approximately 25 employees across 1 continents, including North America. Key team members include Chief Executive Officer / Board Of Directors: P. W.Chief Medical Officer: K. P.Chief Operating Officer: K. M.. Explore Noveome Biotherapeutics, Inc.'s employee directory with LeadIQ.

What industry does Noveome Biotherapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Noveome Biotherapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Noveome Biotherapeutics, Inc. use?

Minus sign iconPlus sign icon
Noveome Biotherapeutics, Inc.'s tech stack includes jsDelivrGoogle Hosted LibrariesTwitter Emoji (Twemoji)Open GraphRSSAndroidYoast SEOContact Form 7.

What is Noveome Biotherapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Noveome Biotherapeutics, Inc.'s email format typically follows the pattern of . Find more Noveome Biotherapeutics, Inc. email formats with LeadIQ.

How much funding has Noveome Biotherapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of November 2024, Noveome Biotherapeutics, Inc. has raised $36M in funding. The last funding round occurred on Aug 17, 2023 for $36M.

When was Noveome Biotherapeutics, Inc. founded?

Minus sign iconPlus sign icon
Noveome Biotherapeutics, Inc. was founded in 2000.
Noveome Biotherapeutics, Inc.

Noveome Biotherapeutics, Inc.

Biotechnology ResearchPennsylvania, United States11-50 Employees

Noveome Biotherapeutics, Inc. is a clinical stage company focused on breakthrough therapies for the regenerative repair of inflamed or damaged tissues.  The company, originally founded as Stemnion, Inc., is located in the heart of Pittsburgh near the Southside Works.  Noveome is passionate about growing its business in Allegheny County and helping the region to become a world leader in  biotherapeutic research and development.

Noveome Biotherapeutics, Inc. is a dynamic biopharmaceutical company with an innovative platform technology that represents a paradigm shift in drug development. Unlike most drugs that are single molecules directed at specific indications, Noveome’s product is a complex mixture of biomolecules that is believed to have the ability to treat a wide range of conditions and injuries. Noveome collaborates with major research centers to advance these therapeutic applications.

Section iconCompany Overview

Headquarters
100 Technology Drive Suite 200 Pittsburgh, PA 15219 US
Phone number
SIC Code
6719 - Offices of Holding Companies, Not Elsewhere Classified
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2000
Employees
11-50

Section iconFunding & Financials

  • $36M

    Noveome Biotherapeutics, Inc. has raised a total of $36M of funding over 6 rounds. Their latest funding round was raised on Aug 17, 2023 in the amount of $36M.

  • $10M

    Noveome Biotherapeutics, Inc.'s revenue is in the range of $10M

Section iconFunding & Financials

  • $36M

    Noveome Biotherapeutics, Inc. has raised a total of $36M of funding over 6 rounds. Their latest funding round was raised on Aug 17, 2023 in the amount of $36M.

  • $10M

    Noveome Biotherapeutics, Inc.'s revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.